[1]Takasaki,Ichiro;Ogashi,Haruna;Okada,Takuya;Shimodaira,Ayaka;Hayakawa,Daichi;Watanabe,Ai;Miyata,Atsuro;Kurihara,Takashi;Gouda,Hiroaki;Toyooka,Naoki[EuropeanJournalofMedicinalChemistry,2020,vol.186]
1998-86-3
91348-51-5
133747-57-6
133747-97-4
260555-43-9
39629-86-2
3441-11-0 | Benzeneethanamine,N-phenyl-, hydrochloride (1:1) | AA00BZZP | MFCD00043990
333-47-1 | 1-Bromo-4-trifluoromethylthiobenzene | AA00C089 | MFCD00040840
349120-86-1 | 2-BROMO-N-(3,5-DIMETHYL-PHENYL)-ACETAMIDE | AA00C0DS | MFCD02974354
37581-34-3 | 4-[(2-Methoxyphenyl)methyl]piperidine hydrochloride | AA00C0L2 | MFCD08437508
34822-90-7 | CYCLOPENTADIENYLTHALLIUM | AA00C0Q6 | MFCD00134141
342013-78-9 | 5-Bromo-N-tert-butylnicotinamide | AA00C0V8 | MFCD01788373
375853-95-5 | 5-(3-Chlorophenyl)nicotinic acid | AA00C0Y3 | MFCD06410265
280027-18-1 | 8-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | AA00C183 | MFCD00060472
2550-27-8 | 3-Methyl-4-phenylbutan-2-one | AA00C1HQ | MFCD00489841
282540-26-5 | Ethyl 6-fluoro-2-methylquinoline-3-carboxylate | AA00C1PZ | MFCD03541053